NASDAQ-100 Gilead Sciences, Inc. [GILD]
Opened The NASDAQ Stock Market
|
| |
Pictured:
John C. Martin, Ph.D., President and Chief Executive Officer of Gilead Sciences, Inc. [GILD], joins
NASDAQ host Ted Coburn, Senior Vice President, The NASDAQ Stock Market to preside over the Market Open.
|
John C. Martin, Ph.D.,
President and
Chief Executive Officer of
Gilead Sciences, Inc.
opened The NASDAQ Stock Market
Friday, April 4, 2003
at NASDAQ's MarketSite
in New York City.
Click here for more information on
Gilead Sciences, Inc.
|
| |
Additional Photographs & Reprint Permissions |
Archived MarketSite Events |
Summary Quote
The NASDAQ Stock Market is proud to welcome Gilead Sciences, Inc. [GILD], a NASDAQ-100 Company to the Market Open.
The company announces the start of the Gilead Access Program, designed to provide access to its novel anti-HIV drug Viread¨ (tenofovir disoproxil fumarate) in the developing world.
About Gilead Sciences, Inc. [GILD]
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide. The company has six marketed products and focuses its research and clinical programs on anti-infectives. Headquartered in Foster City, CA, Gilead has operations in the United States, Europe and Australia.
|
